‘Epigenetic CRISPR’ edits DNA without cutting it | FierceBiotech – FierceBiotech
FierceBiotech |
‘Epigenetic CRISPR’ edits DNA without cutting it | FierceBiotech
FierceBiotech A Salk Institute team created a form of CRISPR/Cas9 that activates specific genes without making breaks in the DNA, which can cut down on harmful side effects. CRISPR/Cas9 can reverse multiple diseases in miceScience News Diabetes and muscular dystrophy could be treated effectively with modified Crispr genetic engineering techniqueThe Independent CRISPR/Cas9 Edits Epigenome with Therapeutic EfficiencyGenetic Engineering & Biotechnology News |
|
Physical therapy essential to Andrews Institute’s stem cell knee cartilage trial — 3 insights
Becker’s Orthopedic & Spine Physical therapy is playing an important role in a clinical trial being conducted at Gulf Breeze, Fla.-based Andrews Institute for Orthopaedics & Sports Medicine, where stem cells are being used to regenerate knee cartilage. Here’s what you should know … |
5newsonline.com |
DNA Is Going Digital – What Could Possibly Go Wrong?
5newsonline.com We’ve even hosted FBI agents from the Weapons of Mass Destruction Directorate here at Colorado State University and previously at Virginia Tech for crash courses on synthetic biology and the associated cyberbiosecurity risks. A year ago, we … |
Coos Bay World |
Gene therapy shows promise against blood-clotting disease
Coos Bay World The therapy supplies the missing gene, using a virus that’s been modified so it won’t cause illness but ferries the DNA instructions to liver cells, which use them to make the clotting factor. The treatment is given through an IV. In a study published … |
Seeking Alpha |
CRISPR Therapeutics: Analysis Of And Update On The B-Thalassemia Franchise
Seeking Alpha The company recently submitted a CTA for CTX-001 (the potential treatment for the blood disorder Beta-thalassemia). It’s the first application for the CRISPR/Cas9 gene-editing platform. CRISPR/Cas9 is a potentially revolutionary platform to launch a … |
